Affiliation:
1. Faculty of Medicine in Pristina, University of Pristina Temporarily Settled in Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia
2. Clinical Hospital Center Pristina, 38205 Gracanica, Serbia
3. Clinical Hospital Center Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia
Abstract
The aim of this study is to determine the demographic and initial clinical characteristics of patients with COVID-19 and their importance in evaluating the severity of the disease. A retrospective study included patients suffering from COVID-19 who were hospitalized at The Department of Infectious Disease of the Clinical Hospital Center Pristina—Gracanica from the beginning of the pandemic until the end of 2020. We compared the symptoms of the disease, radiographic findings of pneumonia, laboratory parameters, duration of symptoms before admission, the difference in the need for certain therapies, and the presence of comorbidities between non-severe and severe groups of patients. Patients with a severe disease were statistically significantly older. Hypertension was significantly associated with severe clinical conditions. Radiographic findings of bilateral pneumonia on admission were much more frequent among the severe group, and these patients’ need for oxygen support was significantly higher. Lower neutrophil and higher lymphocyte counts were statistically significant in the non-severe group. Biochemical parameters at admission also showed statistical significance between the examined groups. Based on our research, we can conclude that a complete overview of the patient, including demographic and laboratory parameters as perhaps the most significant attributes, can help doctors in the timely clinical assessment of patients and, thus, in the timely application of adequate therapeutic protocols in the treatment of COVID-19.
Reference30 articles.
1. World Health Organization (2022). WHO Coronavirus (COVID-19) Dashboard, World Health Organization. Available online: https://covid19.who.int/.
2. Association between Hypoxemia and Mortality in Patients with COVID-19;Xie;Mayo Clin. Proc.,2020
3. The pathophysiology of ‘happy’ hypoxemia in COVID-19;Dhont;Respir. Res.,2020
4. COVID-19 and comorbidities: Deleterious impact on infected patients;Ejaz;J. Infect. Public Health,2020
5. Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19;Battaglini;Front. Immunol.,2022